Adaptimmune Therapeutics PLC Quarterly Other Assets, Current in USD from Q4 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Adaptimmune Therapeutics PLC quarterly Other Assets, Current history and growth rate from Q4 2016 to Q2 2024.
  • Adaptimmune Therapeutics PLC Other Assets, Current for the quarter ending June 30, 2024 was $3.29M, a 86.2% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.29M +$1.52M +86.2% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $2.84M +$1.17M +70.5% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.41M +$485K +25.2% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $1.68M -$29K -1.69% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1.77M -$109K -5.82% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.66M -$439K -20.9% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $1.93M -$155K -7.45% Dec 31, 2022 10-K 2024-03-06
Q3 2022 $1.71M -$2.28M -57.1% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $1.87M +$565K +43.2% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $2.1M -$840K -28.5% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $2.08M +$1.64M +369% Dec 31, 2021 10-K 2023-03-06
Q3 2021 $3.99M +$1.33M +49.8% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $1.31M -$1.62M -55.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $2.94M +$2.04M +224% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $444K -$1.37M -75.5% Dec 31, 2020 10-K 2022-03-14
Q3 2020 $2.66M +$2.19M +465% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $2.93M +$2.33M +389% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $908K +$399K +78.4% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $1.81M +$1.37M +312% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $471K -$456K -49.2% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $599K -$1.37M -69.6% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $509K -$1.66M -76.5% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $439K +$57K +14.9% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $927K Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $1.97M Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $2.17M Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $382K -$594K -60.9% Dec 31, 2017 10-K 2019-02-27
Q4 2016 $976K Dec 31, 2016 10-K 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.